Literature DB >> 20638612

Methicillin-resistant Staphylococcus aureus resistance to non-beta-lactam antimicrobials in the United States from 1996 to 2008.

Jose Bordon1, Ronald N Master, Richard B Clark, Padmaraj Duvvuri, James A Karlowsky, Kwabena Ayesu, Alena Klotchko, Rama Kapoor, Julio Ramirez.   

Abstract

We report the resistance rates of Staphylococcus aureus to non-beta-lactam antimicrobials from The Surveillance Network Database-USA (Eurofins-Medinet, Chantilly, VA). Specimens studied were from lower respiratory tract, wounds, and blood. Patients were stratified by age group and patient setting. There were 2,053,219 isolates of S. aureus and 973,116 of methicillin-resistant S. aureus (MRSA). The MRSA rate increased until 2004 and then leveled off. MRSA showed decreasing resistance to tetracycline and trimethoprim-sulfamethoxazole (TMP-SMX). By age group, the greatest MRSA rate increase was for individuals 17 years and younger. Non-beta-lactam antimicrobials and particularly TMP-SMX should be considered therapeutic options for staphylococcal infections. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20638612     DOI： 10.1016/j.diagmicrobio.2010.03.006

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  8 in total

1.  Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans.

Authors:  Clayton Harro; Robert Betts; Walter Orenstein; Eun-Jeong Kwak; Howard E Greenberg; Matthew T Onorato; Jon Hartzel; Joy Lipka; Mark J DiNubile; Nicholas Kartsonis
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

2.  In vitro activity of ceftaroline against gram-positive and gram-negative pathogens isolated from patients in Canadian hospitals in 2009.

Authors:  James A Karlowsky; Heather J Adam; Melanie R Decorby; Philippe R S Lagacé-Wiens; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

3.  Eleven-Year surveillance of methicillin-resistant Staphylococcus aureus infections at an Academic Health Centre.

Authors:  Safiya Al Musawi; Qassim Alkhaleefa; Samia Alnassri; Aisha M Alamri; Amani Alnimr
Journal:  J Prev Med Hyg       Date:  2022-04-26

4.  Surveillance of antimicrobial resistance among clinical isolates recovered from a tertiary care hospital in Al Qassim, Saudi Arabia.

Authors:  Kamaleldin B Said; Ahmed N Al-Jarbou; Mohammed Alrouji; Hajed O Al-Harbi
Journal:  Int J Health Sci (Qassim)       Date:  2014-01

5.  Geographic variability and anti-staphylococcal activity of the chrysophaentins and their synthetic fragments.

Authors:  Jessica L Keffer; Jared T Hammill; John R Lloyd; Alberto Plaza; Peter Wipf; Carole A Bewley
Journal:  Mar Drugs       Date:  2012-05-22       Impact factor: 6.085

6.  Vancomycin modifies the expression of the agr system in multidrug-resistant Staphylococcus aureus clinical isolates.

Authors:  Vicenta Cázares-Domínguez; Sara A Ochoa; Ariadnna Cruz-Córdova; Gerardo E Rodea; Gerardo Escalona; Alma L Olivares; José de Jesús Olivares-Trejo; Norma Velázquez-Guadarrama; Juan Xicohtencatl-Cortes
Journal:  Front Microbiol       Date:  2015-05-05       Impact factor: 5.640

7.  Methicillin-resistant Staphylococcus aureus in the western region of Saudi Arabia: prevalence and antibiotic susceptibility pattern.

Authors:  Nagwa M El Amin; Hani S Faidah
Journal:  Ann Saudi Med       Date:  2012 Sep-Oct       Impact factor: 1.526

8.  Household risk factors for colonization with multidrug-resistant Staphylococcus aureus isolates.

Authors:  Meghan F Davis; Amy E Peterson; Kathleen G Julian; Wallace H Greene; Lance B Price; Kenrad Nelson; Cynthia J Whitener; Ellen K Silbergeld
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.